Anti-™IE monoclonal antibody

Pre-made anti-™IE monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to ™IE/™IE products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2142-Ab-1/ GM-Tg-hg-IP2142-Ab-2Anti-Human ™IE monoclonal antibodyHuman
GM-Tg-rg-IP2142-Ab-1/ GM-Tg-rg-IP2142-Ab-2Anti-Rat ™IE monoclonal antibodyRat
GM-Tg-mg-IP2142-Ab-1/ GM-Tg-mg-IP2142-Ab-2Anti-Mouse ™IE monoclonal antibodyMouse
GM-Tg-cynog-IP2142-Ab-1/ GM-Tg-cynog-IP2142-Ab-2Anti-Cynomolgus/ Rhesus macaque ™IE monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2142-Ab-1/ GM-Tg-felg-IP2142-Ab-2Anti-Feline ™IE monoclonal antibodyFeline
GM-Tg-cang-IP2142-Ab-1/ GM-Tg-cang-IP2142-Ab-2Anti-Canine ™IE monoclonal antibodyCanine
GM-Tg-bovg-IP2142-Ab-1/ GM-Tg-bovg-IP2142-Ab-2Anti-Bovine ™IE monoclonal antibodyBovine
GM-Tg-equg-IP2142-Ab-1/ GM-Tg-equg-IP2142-Ab-2Anti-Equine ™IE monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2142-Ab-1/ GM-Tg-hg-IP2142-Ab-2; GM-Tg-rg-IP2142-Ab-1/ GM-Tg-rg-IP2142-Ab-2;
GM-Tg-mg-IP2142-Ab-1/ GM-Tg-mg-IP2142-Ab-2; GM-Tg-cynog-IP2142-Ab-1/ GM-Tg-cynog-IP2142-Ab-2;
GM-Tg-felg-IP2142-Ab-1/ GM-Tg-felg-IP2142-Ab-2; GM-Tg-cang-IP2142-Ab-1/ GM-Tg-cang-IP2142-Ab-2;
GM-Tg-bovg-IP2142-Ab-1/ GM-Tg-bovg-IP2142-Ab-2; GM-Tg-equg-IP2142-Ab-1/ GM-Tg-equg-IP2142-Ab-2
Products NameAnti-™IE monoclonal antibody
Formatmab
Target Name™IE
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-™IE monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2142-Ag-1Recombinant multi-species ™IE/ DFNB6 protein


    Target information

    Target IDGM-IP2142
    Target Name™IE
    Gene ID259236,20776,501061,712706,609350,101084267,617572,100065097
    Gene Symbol and Synonyms5131400L21Rik,DFNB6,Mm.87012,RGD1562523,sr,™IE
    Uniprot AccessionQ8NEW7
    Uniprot Entry Name™IE_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000181585
    Target ClassificationN/A

    The target: ™IE, gene name: ™IE, also named as DFNB6. This gene encodes a transmembrane inner ear protein. Studies in mouse suggest that this gene is required for normal postnatal maturation of sensory hair cells in the cochlea, including correct development of stereocilia bundles. This gene is one of multiple genes responsible for recessive non-syndromic deafness (DFNB), also known as autosomal recessive nonsyndromic hearing loss (ARNSHL), the most common form of congenitally acquired inherited hearing impairment. [provided by RefSeq, Mar 2009].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.